Nisa Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.7K | Buy |
4,171
+2,717
| +187% | +$50.6K | ﹤0.01% | 1476 |
|
|
2025
Q1 | $27.9K | Buy |
1,454
+163
| +13% | +$3.12K | ﹤0.01% | 1762 |
|
|
2024
Q4 | $46.5K | Sell |
1,291
-4,559
| -78% | -$164K | ﹤0.01% | 1700 |
|
|
2024
Q3 | $248K | Sell |
5,850
-86
| -1% | -$3.65K | ﹤0.01% | 1226 |
|
|
2024
Q2 | $239K | Buy |
5,936
+1,486
| +33% | +$59.9K | ﹤0.01% | 1268 |
|
|
2024
Q1 | $158K | Hold |
4,450
| – | – | ﹤0.01% | 1363 |
|
|
2023
Q4 | $132K | Sell |
4,450
-1,600
| -26% | -$47.3K | ﹤0.01% | 1377 |
|
|
2023
Q3 | $126K | Hold |
6,050
| – | – | ﹤0.01% | 1438 |
|
|
2023
Q2 | $148K | Buy |
6,050
+5,445
| +900% | +$134K | ﹤0.01% | 1399 |
|
|
2023
Q1 | $25K | Sell |
605
-5
| -0.8% | -$207 | ﹤0.01% | 1943 |
|
|
2022
Q4 | $27K | Buy |
610
+512
| +522% | +$22.7K | ﹤0.01% | 1969 |
|
|
2022
Q3 | $5K | Sell |
98
-52
| -35% | -$2.65K | ﹤0.01% | 2304 |
|
|
2022
Q2 | $9K | Hold |
150
| – | – | ﹤0.01% | 2205 |
|
|
2022
Q1 | $17K | Sell |
150
-25
| -14% | -$2.83K | ﹤0.01% | 2096 |
|
|
2021
Q4 | $21K | Buy |
175
+25
| +17% | +$3K | ﹤0.01% | 1920 |
|
|
2021
Q3 | $18 | Hold |
150
| – | – | ﹤0.01% | 2118 |
|
|
2021
Q2 | $15 | Hold |
150
| – | – | ﹤0.01% | 2176 |
|
|
2021
Q1 | $13 | Hold |
150
| – | – | ﹤0.01% | 2181 |
|
|
2020
Q4 | $14K | Hold |
150
| – | – | ﹤0.01% | 2175 |
|
|
2020
Q3 | $17K | Hold |
150
| – | – | ﹤0.01% | 2059 |
|
|
2020
Q2 | $15K | Sell |
150
-350
| -70% | -$35K | ﹤0.01% | 1837 |
|
|
2020
Q1 | $32K | Buy |
500
+10
| +2% | +$640 | ﹤0.01% | 1626 |
|
|
2019
Q4 | $29K | Buy |
490
+110
| +29% | +$6.51K | ﹤0.01% | 1631 |
|
|
2019
Q3 | $22K | Sell |
380
-80
| -17% | -$4.63K | ﹤0.01% | 1629 |
|
|
2019
Q2 | $30K | Buy |
460
+160
| +53% | +$10.4K | ﹤0.01% | 1564 |
|
|
2019
Q1 | $19K | Buy |
+300
| New | +$19K | ﹤0.01% | 1625 |
|